Nuclear Imaging Market Report

Global Nuclear Imaging Market Size

The global nuclear imaging market was valued at USD 16.69 billion in 2024. The size of the global nuclear imaging market is estimated to value USD 35.86 billion by 2033 from USD 18.17 billion in 2024, growing at a CAGR of 8.87% during the forecast period.

The global nuclear imaging market growth is primarily driven by factors such as an increase in the prevalence of cancer globally and rising cardiac alignments. Hybrid imaging includes two or more modalities to form a new technique; hence hybrid modalities replace the standalone modalities it is expected to propel the market growth. Personalized medicine is an emerging practice of medicine; it includes an individual’s genetic profile to lead to the decision related to prevention; hence, increasing focussing on personalized treatments is expected to boost the market growth.

Moreover, investments by government and private organizations are partnerships to modernize diagnostic imaging centers. Besides, technological advancements and rising diagnostic applications for various diseases will boost the market growth. Researchers, scientists, and technologists bringing systems into clinical practice are expected to expand the market growth over the period. It is proven that diagnosing with nuclear imaging techniques impacts patient management for monitoring tumors and their drug response.

Nuclear imaging equipment pricing and installation require large capital, and investments cannot be affordable by the hospitals in rural areas, which is considered the major restraining factor for market growth. Healthcare facilities in developing countries such as India cannot afford such systems; these higher costs are coupled with the maintenance costs expected to impede market growth. Healthcare providers who purchase costly systems often depend on the reimbursement of the expenditure incurred. Still, sometimes continuous cuts in the reimbursement of diagnostic imaging scans prevent small and medium healthcare facilities from investing in advanced technological nuclear imaging modalities.

REPORT COVERAGE

REGIONAL ANALYSIS

Geographically, North America held the highest share of the global nuclear imaging market in 2024. It is expected to grow at a CAGR of 4.1% during the forecast period. In this regional market, the U.S is estimated to account for the leading share in the next five years due to growing healthcare infrastructure and favorable reimbursement policies. Simultaneously, the U.S. accounted for the largest share of the global Nuclear Imaging market in 2023, spending nearly 20% of its GDP on health. Y-O-Y growth in the prevalence of cancer in the U.S. further adds a boost to the growth rate of the regional market. On the other hand, the Canadian market is witnessed to showcase healthy growth during the forecast period.

The European market was the second-largest regional market globally in 2023 and is estimated to grow at a CAGR of 11.4% during the forecast period. Increasing healthcare expenditure and technological innovations majorly contribute to market growth in Europe. The increasing prevalence of chronic and cardiovascular diseases contributes to the market growth in this region. In Europe, the U.K. held the majority share in this region in 2023, and it is forecasted to share a lucrative share of the European market.

However, the Asia-Pacific region is projected to grow at the highest CAGR during the forecast period due to reasons such as the growing geriatric populace and the surge in the chronic disease population. This regional market is expected to be increasing CAGR by 14.3%. Emerging countries like India, China and Japan significantly contribute to the APAC market, and the support is likely to continue throughout the forecast period. The rising geriatric population is one of the factors propelling the market in the Asia Pacific region.

The Middle East and Africa nuclear imaging market witnessed significant market growth in 2023, and it is projected to increase during the forecast period. An increase in atomic imaging usage for cardiovascular and oncology applications and public and private investments in improving the infrastructure in this region is estimated to propel the market growth over the forecast period.

KEY MARKET PLAYERS

Companies leading the global nuclear imaging market profiled in the report are

• Mallinckrodt plc
• Siemens Medical Solutions
• Hitachi Medical Corporation
• Medtronic Inc.
• General Electric Co. (Healthcare Division)
• IBA Group
• Positron Corporation
• Philips Medical Systems
• Naviscan
• Toshiba Medical Systems Corporation
• Carestream Health
• Lantheus Medical Imaging Inc.
• Cardinal Health Inc.
• Bayer AG

MARKET SEGMENTATION

This research report on the global nuclear imaging market has been segmented and sub-segmented based on the product, application, end-user, and region.

By Product

• Standalone PET Nuclear Imaging
• Standalone SPECT Nuclear Imaging
• Hybrid Nuclear Imaging

By Application

• Oncology
• Cardiology
• Neurology
• Others

By End User

• Hospitals
• Diagnostic Centers
• Research Centers

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa